chlorambucil has been researched along with Thrombophlebitis in 2 studies
Chlorambucil: A nitrogen mustard alkylating agent used as antineoplastic for chronic lymphocytic leukemia, Hodgkin's disease, and others. Although it is less toxic than most other nitrogen mustards, it has been listed as a known carcinogen in the Fourth Annual Report on Carcinogens (NTP 85-002, 1985). (Merck Index, 11th ed)
chlorambucil : A monocarboxylic acid that is butanoic acid substituted at position 4 by a 4-[bis(2-chloroethyl)amino]phenyl group. A chemotherapy drug that can be used in combination with the antibody obinutuzumab for the treatment of chronic lymphocytic leukemia.
Thrombophlebitis: Inflammation of a vein associated with a blood clot (THROMBUS).
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 2 (100.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Abdalla, MI | 1 |
el-D Bahoat, N | 1 |
Morgano, G | 1 |
Patrone, E | 1 |
Muratore, A | 1 |
2 other studies available for chlorambucil and Thrombophlebitis
Article | Year |
---|---|
Long-lasting remission of Behcet's disease after chlorambucil therapy.
Topics: Adrenal Cortex Hormones; Adult; Arthritis; Behcet Syndrome; Chlorambucil; Erythema Nodosum; Female; | 1973 |
[Atypical aspects of leukoses. Venous thrombosis; jaundice].
Topics: Aged; Chlorambucil; Female; Femoral Vein; Humans; Jaundice; Leukemia, Myeloid; Liver Diseases; Male; | 1969 |